Related by context. All words. (Click for frequent words.) 56 Recombinant Activated Factor 55 initiate multicenter 55 multicentre phase 54 Phase II 53 Phase 53 multicenter randomized Phase 53 Phases II 53 ADVANCE PD 53 initiate multicenter Phase 53 balsalazide tablet 52 MW Teesta 52 NHDP phase 52 Ashok Vihar Phase 52 Phase Ib II 51 phase Ib 51 Teesta Stage 51 Initiate Phase 51 CHAMPION PCI 51 Phase IIB 51 confirmatory Phase 51 under NHDP Phase 51 multicenter Phase II 51 Phase III 51 multicenter Phase 51 riociguat 51 Teesta Low 51 randomized controlled Phase 50 multicenter phase 50 Dacogen injection 50 IMPACT IMmunotherapy 50 HCV RESPOND 2 50 Testosterone MDTS ® 50 IMPACT DCM 50 TAL Advantage 50 AMPAKINE CX# 50 Chief Pablo Labra 50 placebo controlled Phase 50 MW Pragati 50 PrevOnco 50 Pivotal Phase II 49 APF# Phase 49 Phase1 49 Phase Ib clinical 49 Second Pivotal Phase 49 Los Toldos 49 label multicenter Phase 49 Photo Hayne Palmour 49 AKT inhibitor 49 Successfully Completes Phase 49 CRMD# 49 blinded randomized placebo controlled 49 GRNVAC1 49 avanafil PDE5 inhibitor 49 thorough QT 49 Dyloject TM 49 PEARL SC 49 Phase IV 49 MoxDuo ® 49 MEND CABG 49 IIa clinical 48 valproate sodium 48 Commences Phase 48 SAGD Phase 48 EXPLORE Xa 48 Commissioner Sixto Esquivias 48 treatment naive genotype 48 XIENCE TM 48 phase IIa 48 Phase #b/#a 48 NHDP Phase 48 Phase Ib study 48 phase IIIb 48 Exherin TM 48 GLP toxicology studies 48 Entereg TM 48 Jegurupadu 48 Phase III multicenter 48 vinorelbine tartrate 48 LUX Lung 48 Dose Ranging Study 48 OLpur TM MD 48 Phase IIb clinical trials 48 ACCLAIM COPD 48 NP2 Enkephalin 48 GLP1 agonist 48 Pimavanserin 48 Testosterone MDTS R 48 Lofexidine 48 initiate Phase IIa 48 armodafinil Tablets C 48 Comet Assay 47 Khongman Zone 47 oxypurinol 47 #.# AJ Foyt 47 HCV SPRINT 47 COSTAR II 47 vaginally administered lidocaine 47 OvaRex ® MAb 47 hGH CTP Phase 47 Initiated Phase 47 Bayer HealthCare Onyx Pharmaceuticals 47 PA# [002] 47 Scopus Affiliation Identifier 47 Proellex TM 47 Paul Steigleder 47 Phase 1a clinical 47 TASKi3 47 LUMINATE 47 Panzem ® 47 STRIDE PD 47 Androxal TM 47 severe hypercholesterolemia 47 Medidur TM FA 47 BRIM2 47 Phase IIA 47 preclinical pharmacokinetic 47 Mycophenolate Mofetil 47 Ozarelix 47 Zenvia Phase III 47 pivotal bioequivalence 47 Cardene ® 47 ENDEAVOR IV 47 LUNESTA TM 47 Heirok Part 47 Phase IIb III 47 phase IIa clinical 47 Subphase 47 JZP 47 REUTERS Claro Cortes 47 FOLOTYN ® 47 Degarelix 47 Pivotal Phase III 47 PSMA ADC 47 phase IIb 47 Roflumilast 47 RSD# 46 Pivotal Phase 46 Eldest Inheritance Book 46 Forodesine 46 OPT CHF 46 multicenter dose escalation 46 Prostate AdenoCarcinoma Treatment 46 PrevOnco ™ 46 son Librado Pina 46 Timothy W. Scee 46 Cloretazine 46 Contrast Echocardiography 46 TASKi2 46 randomized controlled multicenter 46 Saforis 46 rhIGFBP 3 46 PT Pelindo 46 BRIM3 46 Commence Phase 46 Aryplase 46 BLP# Liposome Vaccine 46 mertansine 46 Randomized phase 46 REVIVE TA 46 CDAD Clostridium difficile 46 fosbretabulin 46 Hypoactive Sexual Desire Disorder 46 visilizumab 46 ENRICH trial 46 CLL SLL 46 BY FRANK RADOSEVICH 46 trastuzumab DM1 T DM1 46 Lu AA# 46 pharmacokinetic PK study 46 attorney Alonzo Wickers 46 intravenous methylnaltrexone 46 RE SURGE 46 DDP# 46 multicenter randomized controlled 46 rALLy clinical trial 46 TRELSTAR R 46 APPRAISE 46 Phase III registrational 46 alvimopan 46 MEND CABG II 46 torezolid phosphate 46 Charles L. Dimmler 46 BY GUILLERMO 46 By Linwood Outlaw 46 REG2 46 TLK# 46 SinuNase TM 46 SCENESSE ® 46 reslizumab 46 Phase III confirmatory 46 ularitide 46 ganaxolone 46 clonidine hydrochloride 46 OLpur TM H2H 46 BrachySil TM 46 Huntexil 46 AZX# Phase 46 Phase 2b study 46 Demolizer R 46 dose escalation Phase 46 MoxDuo R 45 phase IIb clinical 45 Phase 1a 45 investigational protease inhibitor 45 patientswith 45 JunJing III 45 stage IIIb 45 midstage clinical 45 PI3K/Akt pathway inhibitor 45 implantable centrifugal rotary 45 Tarceva TM 45 Phase 2b kidney transplant 45 Control Programme NACP 45 Okhla Phase 45 dose escalation clinical 45 overactive bladder AA# 45 REVIVE Diabetes 45 RELOVAIR ™ 45 CLIRS 45 including eniluracil ADH 45 PFO migraine 45 Laurance Kaiser 45 Phase lll 45 elotuzumab 45 ENGAGE AF TIMI 45 FDA Investigational Device 45 initiated confirmatory Phase 45 BiTE antibody MT# 45 oral treprostinil 45 acyclovir Lauriad R 45 PRECISE Trial 45 Sapacitabine 45 MAGE A3 ASCI 45 XL# SAR# 45 Panzem R NCD 45 Hyphanox 45 EOquin TM phase 45 IND submission 45 gallium nitrate 45 rindopepimut 45 subcutaneous methylnaltrexone 45 Dextofisopam 45 cannabinor 45 Biglow Canyon Phase 45 Phase III Clinical Trials 45 opioid induced bowel dysfunction 45 subcutaneous PRO 45 George Brent Mickum 45 PRE SURGE 45 PREGNANT PROCHIEVE Extending GestatioN 45 AERAS-#/Crucell Ad# 45 Randomized Evaluation 45 CIP ISOTRETINOIN 45 tramiprosate Alzhemed TM 45 Phase 1b 45 generation purine nucleoside 45 Intra arterial 45 Cardene R 45 Pirandello Henry 45 ATTAIN 45 NK1 45 STEALTH C 45 IIb clinical trial 45 KRN# 45 Enzastaurin 45 IL# PE#QQR 45 Syncria albiglutide 45 AeroLEF 45 aclidinium bromide 45 multicentre prospective 45 pharmacokinetic PK 45 budesonide foam 45 galiximab 45 DSMB recommended 44 candidates Dyloject TM 44 Grande MK 44 YONDELIS 44 Initiates Clinical 44 cetrorelix pamoate 44 BEMA Granisetron 44 HepeX B TM 44 tiapamil 44 Magnesium Hydroxide 44 treatment naïve genotype 44 Prosaptide 44 initiate Phase IIb 44 Phase III Pivotal 44 gunman Abdo Ibssa 44 BESST 44 PDX pralatrexate 44 transmucosal delivery system 44 Company Vascular Intervention 44 SNT MC# 44 randomized Phase IIb 44 pharmacodynamic PD 44 multicenter Phase III 44 Punatsangchu 44 By Nate Delesline 44 Raw #/#/# Punjab 44 acute mania 44 gemcitabine Gemzar ® 44 Dosage Form 44 multidose dry 44 seliciclib CYC# 44 LEP ETU 44 fidaxomicin Phase 44 Mucopolysaccharidosis 44 RhuDex 44 Zenvia ™ 44 eltrombopag 44 cancer neuroendocrine tumor 44 DUROS 44 phase IIb III 44 Androgel R 44 ACCLAIM II 44 severe oral mucositis 44 Iluvien TM 44 bardoxolone 44 randomized multicenter Phase III 44 examining REOLYSIN 44 phase Ib clinical 44 Trauma Wounds 44 Zemplar Capsules 44 albiglutide 44 comparing alemtuzumab 44 Atiprimod 44 By PAYTON TOWNS 44 Gabapentin GR 44 Augment Injectable 44 oral methylnaltrexone 44 E. Korta 44 JAK inhibitor 44 ADMIRE HF 44 Phase IIa Clinical Trial 44 Goldcrest Dreams 44 Phase IIIb 44 Ceflatonin R 44 Luveniq 44 LAKE IROQUOIS 44 Schematic Design 44 Aplidin R 44 Pivotal Trial 44 William C. Eacho 44 AMVISC ® AMVISC ® 44 controlled multicenter Phase 44 GSK# [002] 44 Henry Schwaller 44 LCP AtorFen 44 Phase IIb 44 Engage Analytics 44 lingual spray 44 Plicera 44 By Denes Husty 44 Sutent sunitinib malate 44 metallurgical flowsheet 44 assessing T DM1 44 essential blepharospasm 44 Liraglutide Effect 44 EGS# 44 Surfaxin LS 44 MIVI III 44 Omnitarg 44 opioid bowel dysfunction 44 Protease Inhibitor 44 CML CP 44 Rapeseed Rajasthan #/#.# # 44 Phase Ib Clinical Trial 44 IIa clinical trials 44 Phase 2b 44 isavuconazole 44 Phase 1b clinical trials 44 recombinant PSMA vaccine 44 receptor tyrosine kinase inhibitor 44 investigational humanized monoclonal antibody 44 TMC# C# 44 Curaxin CBLC# 44 Ziprasidone 44 Silodosin 44 By SL FRISBIE 43 Solorel 43 Kahalalide F 43 CORLUX potent GR 43 AeroLEF TM 43 Dose escalation 43 By JAMES JOYCE 43 EOquin 43 titration phase 43 JunJing II 43 miconazole Lauriad R 43 nalbuphine ER 43 phase IIb trial 43 baminercept 43 OMS# 43 Anturol TM 43 HYCAMTIN 43 TBC# 43 bicifadine 43 MAA submission 43 Intravenous IV 43 MERLIN TIMI 43 Phase III placebo controlled 43 human microdosing 43 Colibri II 43 Phase IIIb study 43 BLA filing 43 Phase 1b clinical 43 Eniluracil 43 BY LAWRENCE LATANE 43 BY MARCUS THOMPSON 43 Tesetaxel 43 TUI Mein Schiff 43 TNRDC 43 Temsirolimus 43 Upper Trishuli 43 RSD# oral 43 IND Investigational New 43 CPV Keenan 43 peginesatide 43 PDE4 inhibitor 43 Pre RELAX AHF 43 G. Tracy Mehan 43 THE GODFATHER PART 43 Rescula 43 MKC# MT 43 Ostabolin C TM 43 By LEO SHANE 43 Heap Leach Project 43 Ocrelizumab 43 transurethral 43 CAMMS# 43 randomized discontinuation 43 dose escalation phase 43 randomized Phase 2b 43 BY RICH MCCRACKEN 43 R roscovitine 43 Phase Ib IIa 43 PF # [002] 43 cathepsin K inhibitor 43 Randomised 43 Nuvion 43 granted Ortec 43 Oluvil Port 43 omacetaxine mepesuccinate 43 multicentre randomized 43 Phase 2b trial 43 generation rotary VAD 43 trastuzumab DM1 43 Rezular 43 clinical trials Multikine 43 Cinacalcet HCl 43 R Bambuterol 43 CIP TRAMADOL ER 43 EURIDIS 43 INSPIRE Trial Phase III 43 relapsing multiple sclerosis 43 octreotide implant 43 selectin antagonist 43 JunJing II Phase 43 Daclizumab 43 Novolimus 43 preclinical toxicology 43 oral RELISTOR 43 TEMSO 43 CALGB # [002] 43 prospective randomized multicenter 43 MDUFMA 43 Zerenex ™ 43 canagliflozin 43 midstage trials 43 Fx #A 43 ORAL Solo 43 NUVIGIL ® 43 Aclidinium 43 fostamatinib 43 SMITH INTERNATIONAL INC. 43 alvespimycin 43 By Arek Sarkissian 43 Antiarrhythmic 43 Corlux 43 adecatumumab MT# 43 Phase IIa clinical 43 Frank D. DiLiddo 43 Phase IIIb clinical 43 LymphoStat B Phase 43 inotropes 43 protamine sulfate 43 Intrathecal 43 ATPace 43 Tomahawk Block 43 TKB# 43 confirmatory Phase III 43 methylnaltrexone 43 MVax 43 dose cohort 43 orally dosed 43 PREOS R 43 DEB# 43 C #A Globemaster 43 Frank Radosevich 43 Phase 2a clinical trials 43 AlleRx 43 serine protease inhibitor CU# 43 selective A2A adenosine receptor 43 TEIS 43 Cloretazine ® 43 Phase Ib clinical trials 43 Phase 1b Clinical Trial 43 Munda Dam 43 ART THOMPSON 43 publisher Orage Quarles 43 ITAX 43 Elagolix 43 APEX PD 43 NEO3 43 novel histone deacetylase 43 argatroban 43 Patient Controlled Analgesia 43 Phase IIb trials 43 PRIMO CABG2 43 ALSYMPCA 42 LEVADEX TM 42 Urocortin 2 42 Pharmos pipeline 42 Factor VIIa 42 BY ART THOMPSON 42 Carbidopa Levodopa 42 Gentamicin Surgical Implant 42 Pharmacokinetic Study 42 Councilman Ed Larvadain 42 Phase III Psoriasis 42 sodium thiosulfate STS 42 VARIVAX 42 recurrent glioma 42 dose titration 42 huC# DM4 42 Curtis G. Solsvig 42 Novartis Trileptal 42 dependent kinase inhibitor 42 evaluating mipomersen 42 telaprevir dosing 42 lorvotuzumab mertansine 42 Phase Ib 42 Confirmatory Phase 42 pegloticase 42 BCom Part 42 denounce Pope Shenouda 42 apricitabine 42 ® daptomycin 42 GALNS 42 #km 2D seismic 42 BY ADRIAN NEMES 42 Viprinex TM 42 GW MILLER 42 rotary VAD 42 pivotal Phase 42 oxycodone hydrochloride 42 AIMM trial 42 Non Aqueous 42 Randomized Phase II 42 Matrix Phase 2b 42 liposomal amphotericin B 42 injectable diclofenac 42 GSK# [001] 42 trial evaluating Prochymal 42 TMC# [002] 42 BrahMos Block 42 HCl capsules 42 Buspirone 42 diabetic neuropathic pain 42 lead Aganocide compound 42 GLOBAL MARKET PERSPECTIVE 42 TACI Ig 42 Study Evaluating 42 Dinner Theatre Goodfield 42 D NON SUPPORT 42 ZYBRESTAT fosbretabulin 42 Glybera R 42 Acetavance TM intravenous acetaminophen 42 MAP# 42 PROTECT AF 42 Panzem R 42 recombinant Factor 42 initiated Phase Ib 42 Esomeprazole 42 Phase IIb dose 42 docetaxel Taxotere R 42 ARDIS 42 Phase 2b Trial 42 Operation Pangea 42 Guanilib 42 oral sapacitabine 42 Zerenex 42 ELACYT 42 Urocidin 42 BEMA Buprenorphine 42 romidepsin 42 ZACTIMA 42 PMA submission 42 hypoxia activated prodrug 42 IMA# 42 Edoxaban 42 Oglemilast 42 Randomized Phase 42 Universite Montpellier 42 ® pramlintide acetate 42 Phase IIa trial 42 LibiGel ® 42 non nucleoside HCV 42 IIb 42 tapentadol 42 confirmatory clinical 42 ATL# [001] 42 calcium calmodulin dependent 42 ATTRACT 42 AIR CF2 42 Flutiform ™ 42 QNEXA ® 42 budesonide MMX 42 Phase IIb kidney transplant 42 MIST II 42 LB# [003] 42 Phase Ib IIa clinical 42 oral rivaroxaban 42 Oxypurinol 42 REOLYSIN ® 42 initiate Phase Ib 42 modafinil Tablets C 42 Denufosol 42 Aflibercept 42 SAGD pilot 42 GOUT 42 incyclinide 42 Phase III Clinical Trial 42 phases IIb 42 Carboxymethyl Cellulose 42 trastuzumab emtansine T DM1 42 PEG SN# 42 Trapeza CDO 42 cephalosporin antibiotic 42 ocrelizumab 42 Amoxicillin PULSYS Phase III 42 PROVENGE ® 42 bortezomib Velcade 42 RhuDex ® 42 GAMMAGARD 42 double blinded placebo 42 MPM Bio 42 Suncor Firebag 42 PRT# 42 inhaled AAT 42 nab paclitaxel 42 EVIZON TM 42 non nucleoside inhibitor 42 Phase 2a 42 Lovaxin C 42 PG Acie Law 42 ChronVac C ® 42 nimodipine 42 Epoetin 42 studies evaluating satraplatin 42 dacetuzumab SGN 42 Advaxis Phase 42 Almorexant 42 novel synthetic peptide 42 JUDE C. 42 MKC# 42 PRECiSE 42 APTIVUS 42 Trabectedin 42 PC DAC Exendin 42 drug pipeline TAFA# 42 Zerenex Phase 42 telomerase therapeutic 42 CEQ# 42 Tamsulosin 42 ACUROX TM Tablets 42 phase III ACCLAIM 42 BY DOUGLAS HANKS 41 labial herpes 41 MUTP II 41 IONSYS TM 41 Phase 2b clinical trials 41 SYMMETRY trial 41 Ispinesib SB # 41 Aplidin 41 celgosivir 41 SAR# [004] 41 OvaRex R 41 tasisulam 41 RAF kinase 41 JK Hage 41 huN# DM1 41 Phase 2a trial 41 NYHA Class II 41 Continuous Emission 41 Aquavan 41 cilengitide 41 ANTEGREN 41 biliary tract cancer 41 JP-#/fipamezole 41 double blinded randomized 41 Hydrochlorothiazide 41 OncoGel 41 Multiple Ascending Dose 41 Rifamycin SV MMX 41 Quinamed 41 immunosuppressive compound 41 ENDEAVOR III 41 LibiGel testosterone gel 41 metered dose inhaler MDI 41 pancrelipase 41 Proxinium TM 41 Vitus Investments 41 IMPACT DCM clinical 41 Initiates Phase II 41 Phase 2b clinical 41 prosecutor Stuart Dunnings 41 Multicenter Phase 41 dihydroergotamine DHE 41 Efficacy Results 41 Topoisomerase 41 oral prodrug 41 Lockerby Depth 41 Xcellerated T Cells 41 Hedgehog pathway inhibitor 41 EyeGate R 41 bearingless fully magnetically levitated 41 Biliary 41 IMC #B 41 pharmacodynamic effects 41 STTR Phase 41 Phase IIb Clinical Trial 41 Vitaxin 41 Phase #b/#a clinical 41 relapsed refractory multiple myeloma 41 Ketotransdel 41 OncoVex 41 Phase #/#a clinical 41 Alequel ™ 41 Initiates Phase 2b 41 PMSSY 41 Fast Tracked Phase 41 TREAT ALS 41 pharmacokinetics PK 41 LAS# [002] 41 fistulizing Crohn disease 41 stammering monarch George 41 forodesine 41 Vicriviroc 41 Phase 2a clinical 41 NHDP Phase III 41 Greek Orthodox Patriarch Theofilos 41 CONSERV 41 Evoltra TM 41 Truvada tablets 41 avanafil 41 Population Enumeration 41 Baqiao 41 Phase III psoriasis 41 rumored Tha Carter 41 VTEM airborne surveys 41 urocortin 2 41 lomitapide 41 Pirfenidone 41 rALLy trial 41 bapineuzumab AAB 41 cyclobenzaprine 41 registrational Phase 41 M. HOPPER 41 Pivotal Trials 41 CLIRS trial 41 MVA MUC1 IL2 41 initiate Phase 1b 41 Huaiyin Power Plant 41 rEV# 41 ProCord 41 ABSORB trial 41 NVA# 41 rPA anthrax vaccine 41 hepatitis B vaccine Heplisav 41 feasability study 41 PTH analogue 41 TWRA Region 41 ToxCast TM 41 HuMax EGFr 41 Cephalosporin 41 DYNAMICS RESEARCH CORPORATION CONDENSED 41 PRISM reactor 41 MARVEL Trial 41 QLT# 41 dextromethorphan quinidine 41 trodusquemine 41 Libby adit 41 BAY #-# 41 generation URAT1 inhibitor 41 placebo controlled dose escalation 41 efficacy endpoint 41 dosing cohorts 41 blinded randomized 41 candidate torezolid phosphate 41 PROACT 41 Initiates Phase 41 TriActiv R 41 Pharmacokinetic PK 41 kilometer 2D seismic 41 Enobia 41 cromolyn sodium 41 thrombin topical bovine 41 VICTOR E1 41 Mipomersen 41 LUVENIQ 41 MW Parbati 41 BiTE R 41 Ofatumumab 41 novel oral anticoagulant 41 dexanabinol 41 Cloretazine R VNP#M 41 VALOR trial 41 Traficet EN 41 ALN VSP Phase 41 ondansetron hydrochloride 41 randomized multicenter 41 Luramist TM 41 antibody MAb 41 RECENT INDUSTRY ACTIVITY 41 randomized multicenter trial 41 neurogenic orthostatic hypotension 41 Middle Vaitarna 41 BCX# 41 NTPC Sipat 41 Phase 2b Clinical Trial 41 Azedra 41 placebo controlled Phase III 41 lorcaserin Phase 41 Feasibility Trial 41 therapy enteral nutrition 41 TELCYTA 41 Initiate Phase II 41 exploratory Phase IIa 41 ILLUMINATE 41 Efficacy Trial 41 Lauriad ® 41 systemic Phase 1b 41 GEH Generation 40 ACTIVE W 40 Annamycin 40 BiovaxID Phase 40 Phase IIa proof 40 procainamide 40 Alocrest 40 Prodarsan 40 Trelstar 40 ANCHOR trial 40 Cancer Antigen 40 small volume parenterals 40 Joseph A. Yanchik 40 Reporter Daarel Burnette 40 Orally administered 40 Allain Duhangan 40 phase IIb study 40 Phase #/#a 40 Clinical Trial Evaluating 40 sevelamer carbonate 40 alogliptin 40 tolevamer 40 TELINTRA R 40 Bohol Irrigation 40 occlusion PAO 40 acute peripheral arterial 40 Vascular Inflammation 40 Fibrillex TM 40 TransMID 40 multicenter randomized placebo controlled 40 Felodipine 40 5alpha reductase 40 Talotrexin 40 oral ridaforolimus 40 Cardene IV 40 Biopharmaceuticals AG 40 NSABP B 40 Edwin M. Fayia 40 solanezumab 40 cGMP manufacture 40 Oral NKTR 40 Cetrorelix 40 ForHealth Technologies 40 stated Michelle Berrey 40 INCB# [002] 40 THROMBIN JMI R 40 Completes Patient Enrollment 40 Phase IIb Trial 40 ASA# 40 R armodafinil Tablets 40 intravitreal implant 40 Gilbert Dewey Gaedcke 40 RECORD1 40 MDS AML 40 LEVADEX ™ 40 EPC# 40 Singer Loudon Wainwright 40 Phase III ThermoDox 40 CB2 selective receptor agonist 40 PRIMO CABG 40 Phase Ia 40 label multicenter randomized 40 unique alkylating agent 40 orBec 40 aclidinium 40 MIRCERA 40 MGd 40 Amrubicin 40 NO# [002] 40 Phase IIa 40 eliglustat tartrate 40 fidaxomicin Phase 3 40 Clabber Creek 40 volociximab 40 Shigamabs ® 40 IIa trials 40 Capacity Expansion Project 40 pivotal Phase III 40 cutaneous T cell 40 ONCONASE R 40 Spiegelmer ® 40 Oilservice Conference TM 40 designated HVTN 40 Lucanix R 40 randomized #:#:# 40 john @ baltsun.com 40 Shellgel TM injectable viscoelastic 40 pharmacokinetic studies 40 SUPPLEMENTARY DATA SCHEDULE 40 ruxolitinib 40 ofatumumab HuMax CD# 40 B. Henneman 40 anticancer compound 40 Stimuvax R 40 Zaleplon 40 ongoing Phase 1b 40 Hedgehog antagonist 40 leading oral taxane 40 eculizumab 40 Iron Sucrose 40 catheter occlusion 40 oglemilast 40 Phase III HEAT 40 Fexofenadine 40 opioid naive 40 Dantrium R 40 Phase III pivotal 40 B. Jemmott 40 RONG GONG LIN 40 BNS Split Corp. 40 macrolide antibiotic 40 Stds 40 Tyrima 40 Micrium uC OS 40 Collagen Type 40 PEG IFN 40 Elder Kingdoms 40 RI Prichard 40 Bella Venezia 40 AMVISC R AMVISC R 40 ENACT 40 IIIA NSCLC 40 BrachySil 40 Genz # 40 Diamyd r vaccine 40 TAXUS IV 40 GATTEX ™ 40 XL# XL# XL# 40 Rigel R# 40 histone deacetylase HDAC inhibitor 40 phase 2a 40 Metastatic Melanoma 40 BENICAR HCT 40 sunitinib malate 40 Albuferon Phase 40 Dose Escalation Study 40 Cefazolin 40 Nicholas Mullane 40 KNS # 40 crofelemer 40 paclitaxel poliglumex 40 NovaStor NovaBackup 40 Lenocta 40 Intravenous Equipment 40 Wide Procurement SEWP 40 Phase 2b Study 40 Arthur Lemann 40 EchoCRT 40 Biphasic 40 registrational trials 40 failure NYHA 40 eniluracil 40 multicentre 40 Lesotho King Letsie 40 initiate Phase 2b 40 Clinical Trial Results